Kit for predicting developmental status of bovine embryo and use thereof in preimplantation genetic diagnosis
By detecting CNVR combinations in bovine embryo samples and using artificial intelligence models to predict embryonic development status, the problem of difficulty in identifying early embryonic CNVs in existing technologies has been solved, thereby improving embryonic development rate and pregnancy rate.
Patent Information
- Application Number
- PCT/CN2025/145993
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-03
- Filing Date
- 2025-12-26
- Publication Date
- 2026-11-19
AI Technical Summary
Existing technologies struggle to accurately identify early genomic variations in bovine embryos, particularly CNVs, leading to abnormal embryonic development and low pregnancy rates.
By detecting the copy number or relative content of each CNVR in the CNVR combination of bovine embryo samples, an artificial intelligence model is used to make predictions, and the embryonic development status is judged in combination with the judgment threshold to guide implantation decisions.
It improved the rate of normal embryo development and pregnancy after transplantation, and reduced the rate of embryonic developmental arrest, providing a theoretical basis for bovine embryo production and breeding.
Smart Images

Figure PCTCN2025145993-FTAPPB-I100001 
Figure PCTCN2025145993-FTAPPB-I100002 
Figure PCTCN2025145993-FTAPPB-I100003
Abstract
Description
A kit for predicting bovine embryonic developmental status and its application in preimplantation diagnostics.
[0001] Cross-reference to related applications
[0002] This application claims priority to the following two patent applications: Chinese Patent Application No. 202510625811.9, filed on May 15, 2025, entitled "A kit for predicting the developmental state of bovine embryos and the CNVR combination thereof," and Chinese Patent Application No. 202510729833.X, filed on June 3, 2025, entitled "A kit for predicting the developmental state of bovine embryos and its application in preimplantation genetic diagnosis," the entire contents of which are incorporated herein by reference. Technical Field
[0003] This invention belongs to the field of molecular genetic biology, specifically relating to a kit for predicting the developmental status of bovine embryos and its application in preimplantation genetic diagnosis. Background Technology
[0004] In vitro embryo production (IVP) technology has been widely used in livestock production. It is not only a primary technique for propagating superior breeds but also accelerates population genetic progress by shortening generation intervals and increasing selection intensity. In recent years, the number of bovine IVP embryos produced globally has shown a rapid growth trend, becoming a major source for commercial bovine embryo transfer. However, IVP technology still faces bottlenecks such as embryonic developmental abnormalities, developmental arrest, and low pregnancy rates after transfer. Studies have found that the rate of chromosomal abnormalities in embryos under in vitro conditions is as high as 25%-40%, leading to embryonic developmental arrest, pregnancy failure, and even birth defects, causing serious economic losses. Therefore, it is necessary to conduct in-depth research on the factors causing embryonic developmental arrest, identify key genomic variations that can determine the embryonic developmental status, and effectively reduce the rate of embryonic developmental arrest and improve the pregnancy rate after transfer by detecting relevant genetic variations or molecular markers, thereby further improving the efficiency of IVP production.
[0005] Common genomic variations are generally classified into three categories: single nucleotide polymorphisms (SNPs), small insertions and deletions (INDELs) between 2-50 bp, and copy number variations (CNVs) larger than 50 bp. Embryonic developmental abnormalities are closely related to genomic structural variations, with CNVs significantly impacting gene expression and function. Due to their larger-scale genomic alterations, CNVs may directly participate in regulating key embryonic developmental pathways. CNVs are widely distributed across the genome, and common methods for detecting them include microarrays and sequencing. However, traditional CNV detection methods (such as microarray technology) have limitations in resolution, sensitivity, and accuracy, making it difficult to accurately identify various variations in early embryos. With the rapid development and cost reduction of high-throughput sequencing technology, whole-genome sequencing has become the preferred method for CNV detection. However, how to screen for CNV biomarkers specific to developmental status from complex data remains a pressing scientific problem. In humans, studies have already used CNV detection for the diagnosis of early embryonic health.
[0006] Currently, research on the detection and analysis of CNV-specific variations in bovine embryos is relatively scarce. In-depth analysis of the factors causing embryonic developmental arrest and identification of key CNVs that can determine embryonic developmental status can effectively reduce the rate of early embryonic developmental arrest and improve post-implantation pregnancy rates. Therefore, identifying key CNVs affecting the developmental status of early bovine embryos is of great significance for embryo production, screening, and diagnosis; this can not only improve the rate of normal embryonic development and post-implantation pregnancy rates, but also provide important theoretical basis for the efficient production of bovine in vitro embryos and the optimization of embryo breeding technologies.
[0007] Invention Overview
[0008] The purpose of this invention is to predict the developmental status of bovine embryos cultured in vitro and thereby guide bovine embryo implantation, that is, to conduct preimplantation diagnosis of bovine embryos.
[0009] This invention also protects a method for predicting the developmental status of bovine embryos and / or a preimplantation diagnostic method for bovine embryos, which may include the following steps: S1, obtaining the copy number or relative content value of each CNVR in the CNVR combination of the tested bovine embryo sample; S2, inputting the copy number or relative content value into a trained artificial intelligence model to obtain an output value, and comparing the output value with a judgment threshold to obtain the developmental status of the bovine embryo, wherein the developmental status of the bovine embryo is normal development or developmental arrest; the artificial intelligence model is an artificial intelligence model trained with the copy number or relative content value of each CNVR in the CNVR combination of normally developing embryos and developmentally arrested embryos as input data and the probability of developmental arrest of bovine embryos as output; the CNVR combination is CNVR combination 1 or CNVR combination 2.
[0010] The CNVR combination 1 may include CNVR1, CNVR2, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, CNVR8, CNVR9, CNVR10, CNVR11 and / or CNVR12.
[0011] The CNVR combination 2 may include CNVR-Vst5, CNVR-Vst11, CNVR-Vst7 and / or CNVR-Vst4.
[0012] Furthermore, the suitability for bovine embryo implantation can be determined based on the bovine embryo's developmental stage: if the bovine embryo is developing normally, embryo transfer can be performed; if the bovine embryo is in a state of developmental arrest, embryo implantation is not recommended.
[0013] In the above method, the relative content value can be the ratio of the content of CNVR in the genome of the tested bovine embryo to the content of the bovine internal reference gene in the genome of the tested bovine embryo.
[0014] In the above method, the content of CNVR or bovine reference gene in the genome of the tested bovine embryo can be obtained by the following method: using the genomic DNA of the tested bovine embryo as a template, PCR amplification is performed using primer pairs to obtain PCR amplification products, and the content of specific DNA fragments in the PCR amplification products is detected. The nucleotide sequences of some CNVR and reference gene detection primers are shown in Tables 5 and 2.
[0015] In the above method, the copy number of CNVR in the genome of the tested bovine embryo can be obtained by software detection. The software can be CNVcaller or CNVnator.
[0016] This application also provides a data processing device for predicting the developmental status of bovine embryos. The data processing device for predicting the developmental status of bovine embryos may include a memory, a processor, and a computer program stored in the memory, wherein the processor executes the computer program to perform the following steps: P1, data receiving: receiving the copy value or relative content value of each CNVR in the CNVR combination of the bovine embryo sample to be tested, obtaining sample data; P2, data processing: inputting the sample data into a trained artificial intelligence model, obtaining an output value, and comparing the output value with a judgment threshold to obtain the developmental status of the bovine embryo, wherein the developmental status of the bovine embryo is normal development or developmental arrest; the artificial intelligence model is an artificial intelligence model trained with the copy value or relative content value of each CNVR in the CNVR combination of normally developing embryos and developmentally arrested embryos as input data, and the probability of developmental arrest of the bovine embryo as output.
[0017] The CNVR combination is either any of the CNVR combination 1 or any of the CNVR combination 2 described above.
[0018] The suitability for bovine embryo implantation is determined based on the results of bovine embryo development status prediction methods: if the bovine embryo is predicted to be a normally developing embryo, embryo transfer can be performed; if the bovine embryo is predicted to be a developmentally arrested embryo, embryo implantation is not recommended.
[0019] In the aforementioned data processing apparatus, any of the aforementioned relative content values may be the ratio of the content of CNVR in the genome of the tested bovine embryo to the content of the bovine internal reference gene in the genome of the tested bovine embryo.
[0020] In embodiments of the present invention, the decision threshold can be obtained through a receiver operating characteristic (ROC) curve. Specifically, the decision threshold that optimizes classification performance can be found using the ROC curve; the critical point corresponding to the maximum Youden index (the detection value at which the Youden index is maximum) is the decision threshold. The Youden index is the sum of sensitivity and specificity minus 1. Sensitivity is also known as the True Positive Rate (TPR). Specificity is also known as the True Negative Rate (TNR). TPR = TP / (TP + FN). TNR = TN / (TN + FP). TP: True Positive. TN: True Negative. FP: False Positive. FN: False Negative.
[0021] In one embodiment, the data processing device is a data processing device for predicting the developmental status of bovine embryos. In another embodiment, the data processing device is a data processing device for preimplantation genetic diagnosis of bovine embryos.
[0022] In one specific embodiment, the data processing device is a computer device.
[0023] This application also provides a computer-readable storage medium.
[0024] The computer-readable storage medium provided in this application stores a computer program thereon, which, when executed by a processor, implements the steps of the method.
[0025] In some implementations, the computer-readable storage medium is "non-transitory" or "non-temporary".
[0026] This application also provides a computer program (product).
[0027] The computer program (product) provided in this application includes a computer program that, when executed by a processor, implements the steps of the method.
[0028] The computer program products mentioned above can be software products that primarily implement their solutions through computer programs.
[0029] The computer-readable storage medium refers to a carrier for storing data, which may be magnetic tape, disk, floppy disk, optical disk, magneto-optical disk, ROM, PROM, VCD, DVD, hard disk, flash memory, USB flash drive, CF card, SD card, MMC card, SM card, Memory Stick, or xD card, etc.
[0030] Those skilled in the art will understand that the steps of the present invention described above can be implemented using general-purpose computing devices. They can be centralized on a single computing device or distributed across a network of multiple computing devices. Optionally, they can be implemented using computer-executable program code, thereby storing them in a storage device for execution by a computing device. In some cases, the steps can be performed in a different order than described here, or they can be fabricated as separate integrated circuit modules, or multiple steps can be fabricated as a single integrated circuit module. Thus, the present invention is not limited to any particular combination of hardware and software.
[0031] The general-purpose computing device mentioned here typically includes a processor and a memory. The memory is used to store instructions, which, when executed by the processor, cause the computing device to perform "the steps of the present invention".
[0032] The CNVR combination 1 described above can specifically be composed of CNVR1, CNVR3, CNVR6, CNVR7, CNVR9, CNVR10, CNVR11 and CNVR12.
[0033] The CNVR combination 2 described above is specifically composed of CNVR-Vst4, CNVR-Vst5, CNVR-Vst7 and CNVR-Vst11.
[0034] This invention also protects a diagnostic method for bovine embryo implantation, namely, determining whether bovine embryo implantation is possible based on the results of the aforementioned bovine embryo development status prediction method; specifically, if the bovine embryo is predicted to be a normally developing embryo, embryo transfer can be performed; if the bovine embryo is predicted to be a developmentally arrested embryo, embryo implantation is not recommended.
[0035] The present invention also protects a kit for predicting the developmental status of bovine embryos and / or for preimplantation diagnostics of bovine embryos, which may include products for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome and / or products for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome.
[0036] In the kit, CNVR combination 1 may include CNVR1, CNVR2, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, CNVR8, CNVR9, CNVR10, CNVR11 and / or CNVR12. In the kit, CNVR combination 2 may include CNVR-Vst5, CNVR-Vst11, CNVR-Vst7 and / or CNVR-Vst4.
[0037] In the above text, the nucleotide sequence of any of the aforementioned CNVR1 is shown as positions 87257601-87261000 on chromosome 1 of the bovine genome (Bovine Reference Genome ARS-UCD 1.3 version, the same below). The nucleotide sequence of any of the aforementioned CNVR2 is shown as positions 10962442-10967439 on chromosome 6 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR3 is shown as positions 73069301-73075200 on chromosome 7 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR4 is shown as positions 9559601-9564600 on chromosome 15 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR5 is shown as positions 42400401-42411000 on chromosome 17 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR6 is shown as positions 45089601-45097500 on chromosome 19 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR7 is shown as positions 2431101-2439900 on chromosome 20 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR8 is shown as positions 27338101-27364000 on chromosome 25 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR9 is shown as positions 41627101-41632400 on chromosome 15 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR10 is shown as positions 21750901-21754000 on chromosome 23 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR11 is shown as positions 5217901-5222300 on chromosome 27 of the bovine genome. The nucleotide sequence of any of the CNVR12 described above is shown at positions 19154801-19158600 on chromosome 29 of the bovine genome.
[0038] In the above text, the nucleotide sequence of any of the aforementioned CNVR-Vst5 is shown as positions 60638401-60642400 on chromosome 5 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR-Vst11 is shown as positions 71203201-71205200 on chromosome 11 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR-Vst7 is shown as positions 18346401-18350000 on chromosome 7 of the bovine genome. The nucleotide sequence of any of the aforementioned CNVR-Vst4 is shown as positions 44117201-44118800 on chromosome 4 of the bovine genome.
[0039] The purpose of any of the above-described kits is to predict the developmental status of bovine embryos and / or to perform preimplantation genetic diagnosis of bovine embryos.
[0040] The CNVR combination 1 may specifically consist of CNVR1, CNVR2, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, CNVR8, CNVR9, CNVR10, CNVR11 and / or CNVR12.
[0041] The CNVR combination 2 may specifically consist of CNVR-Vst5, CNVR-Vst11, CNVR-Vst7 and / or CNVR-Vst4.
[0042] The CNVR combination 1 can specifically be composed of CNVR1, CNVR3, CNVR6, CNVR7, CNVR9, CNVR10, CNVR11 and CNVR12.
[0043] The CNVR combination 2 can specifically be composed of CNVR-Vst4, CNVR-Vst5, CNVR-Vst7 and CNVR-Vst11.
[0044] In the above kit, the content and / or copy number of CNVR combination 1 or the content and / or copy number of CNVR combination 2 can be obtained by detecting bovine embryo genomic DNA using real-time quantitative PCR.
[0045] In the above kit, the content and / or copy number of CNVR combination 1 or the content and / or copy number of CNVR combination 2 can be the copy number obtained by detection using CNVcaller software or CNVnator software.
[0046] The kit described above, for detecting the content and / or copy number of CNVR combination 1 in bovine embryo genome, may include primer pair CW1 for detecting CNVR1, primer pair CW6 for detecting CNVR2, primer pair CW7 for detecting CNVR3, primer pair CW15 for detecting CNVR4, primer pair CW19 for detecting CNVR6, primer pair CW20 for detecting CNVR7, primer pair SW15 for detecting CNVR9, primer pair SW23 for detecting CNVR10, primer pair SW27 for detecting CNVR11, and / or primer pair SW29 for detecting CNVR12.
[0047] The product for detecting the content and / or copy number of CNVR combination 1 in bovine embryo genome may specifically consist of primer pair CW1 for detecting CNVR1, primer pair CW6 for detecting CNVR2, primer pair CW7 for detecting CNVR3, primer pair CW15 for detecting CNVR4, primer pair CW19 for detecting CNVR6, primer pair CW20 for detecting CNVR7, primer pair SW15 for detecting CNVR9, primer pair SW23 for detecting CNVR10, primer pair SW27 for detecting CNVR11, and / or primer pair SW29 for detecting CNVR12.
[0048] The primer pair CW1 consists of primer CNVR-CW1F with the nucleotide sequence shown in SEQ ID No. 11 and primer CNVR-CW1R with the nucleotide sequence shown in SEQ ID No. 12. The primer pair CW6 consists of primer CNVR-CW6F with the nucleotide sequence shown in SEQ ID No. 13 and primer CNVR-CW6R with the nucleotide sequence shown in SEQ ID No. 14. The primer pair CW7 consists of primer CNVR-CW7F with the nucleotide sequence shown in SEQ ID No. 15 and primer CNVR-CW7R with the nucleotide sequence shown in SEQ ID No. 16. The primer pair CW15 consists of primer CNVR-CW15F with the nucleotide sequence shown in SEQ ID No. 17 and primer CNVR-CW15R with the nucleotide sequence shown in SEQ ID No. 18. The primer pair CW19 consists of primer CNVR-CW19F with the nucleotide sequence shown in SEQ ID No. 19 and primer CNVR-CW19R with the nucleotide sequence shown in SEQ ID No. 20. The primer pair CW20 consists of primer CNVR-CW20F with the nucleotide sequence shown in SEQ ID No. 21 and primer CNVR-CW20R with the nucleotide sequence shown in SEQ ID No. 22. The primer pair SW15 consists of primer CNVR-SW15F with the nucleotide sequence shown in SEQ ID No. 23 and primer CNVR-SW15R with the nucleotide sequence shown in SEQ ID No. 24. The primer pair SW23 consists of primer CNVR-SW23F with the nucleotide sequence shown in SEQ ID No. 25 and primer CNVR-SW23R with the nucleotide sequence shown in SEQ ID No. 26. The primer pair SW27 consists of primer CNVR-SW27F with the nucleotide sequence shown in SEQ ID No. 27 and primer CNVR-SW27R with the nucleotide sequence shown in SEQ ID No. 28. The primer pair SW29 consists of primer CNVR-SW29F with the nucleotide sequence shown in SEQ ID No. 29 and primer CNVR-SW29R with the nucleotide sequence shown in SEQ ID No. 30.
[0049] The kit described above may include primer pair Vst5 for detecting CNVR combination 2 in bovine embryo genome, primer pair Vst11 for detecting CNVR-Vst11, primer pair Vst7 for detecting CNVR-Vst7, and / or primer pair Vst4 for detecting CNVR-Vst4.
[0050] The product described above for detecting the content and / or copy number of CNVR combination 2 in bovine embryo genome may specifically consist of primer pair Vst5 for detecting CNVR-Vst5, primer pair Vst11 for detecting CNVR-Vst11, primer pair Vst7 for detecting CNVR-Vst7, and / or primer pair Vst4 for detecting CNVR-Vst4.
[0051] The primer pair Vst5 can specifically consist of primer CNVR-Vst 5F with the nucleotide sequence shown in SEQ ID No. 3 and primer CNVR-Vst 5R with the nucleotide sequence shown in SEQ ID No. 4. The primer pair Vst11 can specifically consist of primer CNVR-Vst 11F with the nucleotide sequence shown in SEQ ID No. 5 and primer CNVR-Vst 11R with the nucleotide sequence shown in SEQ ID No. 6. The primer pair Vst7 can specifically consist of primer CNVR-Vst 7F with the nucleotide sequence shown in SEQ ID No. 7 and primer CNVR-Vst 7R with the nucleotide sequence shown in SEQ ID No. 8. The primer pair Vst4 can specifically consist of primer CNVR-Vst 4F with the nucleotide sequence shown in SEQ ID No. 1 and primer CNVR-Vst 4R with the nucleotide sequence shown in SEQ ID No. 2.
[0052] The content mentioned above can be a relative content. The relative content can be the content of a relative internal reference gene. The copy number mentioned above can be a relative copy number. The relative copy number can be the copy number of a relative internal reference gene.
[0053] In the above kit, the content and / or copy number of CNVR combination 1 can be the content and / or copy number of CNVR combination 1 relative to the internal reference gene. In the above kit, the content and / or copy number of CNVR combination 2 can be the content and / or copy number of CNVR combination 2 relative to the internal reference gene.
[0054] The internal reference gene mentioned above can be the BTF3 gene.
[0055] The products described above for detecting the content and / or copy number of CNVR combination 1 in bovine embryo genomes may further include primer pairs for detecting an internal reference gene. The products described above for detecting the content and / or copy number of CNVR combination 2 in bovine embryo genomes may further include primer pairs for detecting an internal reference gene.
[0056] The primer pair described above for detecting the internal reference gene can be the primer pair BTF3 for detecting the BTF3 gene.
[0057] The primer pair BTF3 can specifically consist of primer BTF3F with a nucleotide sequence as shown in SEQ ID No. 9 and primer BTF3R with a nucleotide sequence as shown in SEQ ID No. 10.
[0058] In the above kit, the bovine embryo can be a bovine embryo cultured through in vitro fertilization.
[0059] In the above kit, the bovine embryo may be a bovine embryo that has developed to the blastocyst or expanded blastocyst stage.
[0060] The kit may specifically consist of the product for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome and / or the product for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome.
[0061] The kits described above may also include carrier A, carrier B and / or carrier C.
[0062] The carrier A may specifically record the following: using bovine embryos that have developed to the blastocyst or expanded blastocyst stage as the test sample, using arrested bovine embryos that have developed to the blastocyst or expanded blastocyst stage as reference sample 1, and using normal bovine embryos that have developed to the blastocyst or expanded blastocyst stage as reference sample 2, the content and / or copy number of CNVR combination 1 in the test sample, the reference sample 1, and the reference sample 2 are detected; then, based on the differences in the content and / or copy number of CNVR combination 1 in the test sample, the reference sample 1, and the reference sample 2, the embryonic development status of the test sample is predicted or preimplantation genetic diagnosis is performed.
[0063] Specifically, if the content and / or copy number of at least one of CNVR1, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, and CNVR8 in the CNVR combination 1 of the sample to be tested is significantly higher than that of the reference sample 1, it indicates that the CNVR region CNV fragments are largely repeated, which is conducive to healthy embryonic development, i.e., the sample to be tested is developing normally. If the content and / or copy number of CNVR2 in the CNVR combination 1 of the sample to be tested is significantly lower than that of the reference sample 1, it indicates that the CNVR2 region CNV fragments are largely missing, which is conducive to healthy embryonic development, i.e., the sample to be tested is developing normally. If the content and / or copy number of at least one of CNVR9, CNVR11, and CNVR12 in the CNVR combination 1 of the sample to be tested is significantly lower than that of the reference sample 2, it indicates that the CNVR region CNV fragments are largely missing, which is detrimental to embryonic health, and the sample to be tested is prone to developmental arrest or has a high risk of developmental arrest. If the content and / or copy number of CNVR10 in CNVR combination 1 of the sample to be tested is significantly higher than that of the reference sample 2, it indicates that the CNV fragments in the CNVR10 region are highly repetitive, which is not conducive to embryonic health, and the sample to be tested is at high risk of developmental arrest or developmental arrest.
[0064] The carrier C may specifically contain the following: using bovine embryos developed to the blastocyst or expanded blastocyst stage as the test sample, and using normal bovine embryos developed to the blastocyst or expanded blastocyst stage as the reference sample 3, the content and / or copy number of the CNVR combination 2 in the test sample and the reference sample 3 are detected; then, based on the difference in the content and / or copy number of the CNVR combination 2 in the test sample and the reference sample 3, the embryonic development status of the test sample is predicted or preimplantation genetic diagnosis is performed.
[0065] Specifically, if the content and / or copy number of at least one of CNVR-Vst4, CNVR-Vst5, CNVR-Vst7 and CNVR-Vst11 in the CNVR combination 2 in the sample to be tested is significantly higher than that in the reference sample 3, it indicates that there is a large amount of duplication of the CNVR region CNV fragment in the CNVR combination 2, which is not conducive to embryonic health and the sample to be tested is at high risk of developmental arrest or developmental arrest.
[0066] The carrier B may specifically record the following: comparing the copy number or relative content value of each CNVR in CNVR combination 1 or CNVR combination 2 of a bovine embryo that has developed to the blastocyst or expanded blastocyst stage with a determination threshold to determine the developmental status of the tested bovine embryo. Based on the results of the above bovine embryo developmental status prediction method, a diagnosis is made as to whether bovine embryo implantation should be performed; specifically, if the bovine embryo is predicted to be a normally developing embryo, embryo transfer can be performed; if the bovine embryo is predicted to be a developmentally arrested embryo, embryo implantation is not recommended.
[0067] In embodiments of the present invention, the decision threshold can be obtained through a receiver operating characteristic (ROC) curve. Specifically, the decision threshold that optimizes classification performance can be found using the ROC curve; the critical point corresponding to the maximum Youden index (the detection value at which the Youden index is maximum) is the decision threshold. The Youden index is the sum of sensitivity and specificity minus 1. Sensitivity is also known as the True Positive Rate (TPR). Specificity is also known as the True Negative Rate (TNR). TPR = TP / (TP + FN). TNR = TN / (TN + FP). TP: True Positive. TN: True Negative. FP: False Positive. FN: False Negative.
[0068] In an embodiment of the present invention, the copy value or relative content value of each CNVR is input into a trained artificial intelligence model, the output value is analyzed, and the output value is compared with a judgment threshold.
[0069] The above-mentioned kit may specifically consist of any of the products described above for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome and any of the above-mentioned vectors A or B. The above-mentioned kit may specifically consist of any of the products described above for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome and any of the above-mentioned vectors C or B.
[0070] The application of any of the products described above for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome and / or any of the products described above for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome in predicting bovine embryo development status and / or preimplantation genetic diagnosis is also within the scope of protection of this invention.
[0071] The products described above for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome, and the applications of vector A or vector B described above in predicting bovine embryonic development status and / or preimplantation genetic diagnosis, are also within the scope of protection of this invention.
[0072] The products described above for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome, and the applications of vector C or vector B described above in predicting bovine embryonic development status and / or preimplantation genetic diagnosis, are also within the scope of protection of this invention.
[0073] The trained artificial intelligence model described above can specifically be a developmental status discrimination model. Using "developmentally arrested embryos" as true positives and "normally developing embryos" as true negatives, a binomial logistic regression model is established, i.e., a model is constructed using binary classification labels, where the categories are defined as: "0" representing a normally developing embryo and "1" representing a developmentally arrested embryo. The parameters in the model are estimated based on the maximum likelihood method. For any tested embryo, its copy number or relative content value is obtained through detection, and its developmental arrest probability p is calculated using the following formula:
[0074] Where β0 is a constant term, and β1 to β n These are the coefficients of each variable, X1 to X... n p represents the copy number or relative content value of each CNVR, and p / (1-p) is a statistical indicator describing the intensity of an event, called the odds.
[0075] The bovine embryos mentioned above can be bovine embryos cultured through in vitro fertilization. The bovine embryos mentioned above can be embryos developed to the blastocyst or expanded blastocyst stage. The bovines mentioned above can specifically be Chinese Holstein dairy cows. The embryonic developmental status mentioned above can be normal embryonic development or embryonic developmental arrest. The content mentioned above can be a relative content. The copy number mentioned above can be a relative copy number. Normal embryonic development refers to an embryo capable of forming a normal blastocyst structure with a complete inner cell mass and trophoblast cells. Embryos with developmental arrest mentioned above are those that cannot form a blastocyst or cannot expand further, have a missing inner cell mass, or abnormal trophoblast cells. The bovine genome mentioned above can specifically be the bovine reference genome ARS-UCD version 1.3.
[0076] This invention clarifies the impact of large-segment genomic genetic variations (CNVs) on the development of bovine embryos induced by in vitro fertilization. It finds that large duplications of CNV segments in at least one of the regions CNVR1, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, and CNVR8, or large deletions of CNV segments in the CNVR2 region, are beneficial to healthy embryonic development and are potential sites for maintaining normal embryonic development. Conversely, large deletions of CNV segments in at least one of the regions CNVR9, CNVR11, and CNVR12, or large duplications of CNV segments in the CNVR10 region, are detrimental to healthy embryonic development and are potential sites for causing embryonic developmental arrest. This invention identifies 12 CNVRs whose content and / or copy number are closely related to bovine embryo development: If, in a bovine embryo cultured in vitro and developed to the blastocyst or expanded blastocyst stage, the content and / or copy number of CNVR1, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, and / or CNVR8 are significantly higher than those of a stalled bovine embryo developed to the blastocyst or expanded blastocyst stage, or the content and / or copy number of CNVR2 are significantly lower than those of a stalled bovine embryo developed to the blastocyst or expanded blastocyst stage, then the bovine embryo can develop normally and can be transferred; if, in a bovine embryo cultured in vitro and developed to the blastocyst or expanded blastocyst stage, the content and / or copy number of CNVR9, CNVR11, and / or CNVR12 are significantly lower than those of a normal bovine embryo developed to the blastocyst or expanded blastocyst stage, or the content and / or copy number of CNVR10 are significantly higher than those of a normal bovine embryo developed to the blastocyst or expanded blastocyst stage, then the bovine embryo is developmentally arrested, and embryo transfer is not recommended.
[0077] This invention also found that if the content and / or copy number of the four CNVRs (i.e., CNVR-Vst5, CNVR-Vst11, CNVR-Vst7, and / or CNVR-Vst4) in the genome of a bovine embryo cultured in vitro and developed to the blastocyst or expanded blastocyst stage are not significantly different from those of a normal bovine embryo developed to the blastocyst or expanded blastocyst stage, then the bovine embryo can develop normally and can be transferred. If the content and / or copy number of CNVR-Vst5, CNVR-Vst11, CNVR-Vst7, and / or CNVR-Vst4 in the genome of a bovine embryo cultured in vitro and developed to the blastocyst or expanded blastocyst stage are significantly different from those of a normal bovine embryo developed to the blastocyst or expanded blastocyst stage (e.g., the former's content and / or copy number are significantly increased), then the bovine embryo's development is arrested, and embryo transfer is not recommended.
[0078] Therefore, this invention can scientifically determine the transplantation strategy and decision-making for bovine embryos, and has important application value. Attached Figure Description
[0079] Figure 1 shows the specificity detection results of the four CNVR detection primers in Example 2.
[0080] Figure 2 shows the detection of the relative content of CNVR in embryos at different developmental stages in Example 2.
[0081] Figure 3 shows the ROC curves of the prediction model based on the copy number of CNVR-Vst4, CNVR-Vst5, CNVR-Vst7, and CNVR-Vst11 in embryos at different developmental stages.
[0082] Figure 4 shows the relative content of four repetitive CNVRs in embryos at different developmental stages in Example 5.
[0083] Figure 5 shows the relative content of three deletion-type CNVRs in embryos at different developmental stages in Example 5.
[0084] Figure 6 shows the ROC curves constructed based on copy number variations in multiple embryos measured by CNVnator. Embodiments of the present invention
[0085] The present invention will now be described in further detail with reference to specific embodiments. The given embodiments are merely illustrative of the invention and not intended to limit its scope. The embodiments provided below can serve as a guide for further improvements by those skilled in the art and do not constitute a limitation on the invention in any way.
[0086] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available.
[0087] In the following embodiments, the CNV region (CNVR) refers to CNVs detected by different individuals in the detection group. If there are overlapping areas, the CNVs are integrated and merged into a single CNVR.
[0088] In the quantitative experiments in the following examples, three replicate experiments were set up, and the average value of the results was taken.
[0089] Example 1: Copy number variation detection and identification of differential CNVR in embryos at different developmental stages
[0090] I. Obtaining and grouping bovine embryo samples
[0091] The bovine embryo samples used in this embodiment were all Chinese Holstein dairy cow embryos (i.e., bovine in vitro embryos) produced by in vitro fertilization, which developed to the blastocyst or expanded blastocyst stage on days 6-7 after in vitro culture, and were provided by Shandong Aux Livestock Seed Industry Co., Ltd. The bovine embryo samples could be 7 or 10 embryonic trophectoderm cells cut off, or whole embryos. Based on the embryonic development status (embryos that can form a normal blastocyst structure with a complete inner cell mass and trophectoderm cells were considered to be developing normally; embryos that could not form a blastocyst or could not expand further, or had a missing inner cell mass or abnormal trophectoderm cells were considered to be developing arrested), the 43 embryos were divided into a normal development group (hereinafter referred to as the normal group, denoted as the CW group) and a developmentally arrested group (hereinafter referred to as the arrested group, denoted as the SW group), with 23 embryos in the normal group and 20 embryos in the arrested group.
[0092] II. Obtaining and Amplifying Genomic DNA from Bovine Embryo Samples
[0093] use The Single Cell Kit (Qiagen) was used to extract and amplify genomic DNA from bovine embryo samples, and the genomic DNA from all bovine embryo samples was detected and its concentration determined by agarose gel electrophoresis.
[0094] Agarose gel electrophoresis results showed that all embryonic samples exhibited clear master bands of genomic DNA, with no obvious degradation or non-specific amplification bands, indicating that the integrity and purity of the amplified products met the standards. The concentration range of genomic DNA in all amplified embryonic samples was 111.48 ng / μL-1360.80 ng / μL, and the total amount was 4.24 μg-53.07 μg.
[0095] III. Copy number variation detection and identification of differential CNVR in embryos at different developmental stages
[0096] 1. Library construction and sequencing
[0097] Library construction and high-depth sequencing (60G / sample) were performed on the genomic DNA of all bovine embryo samples to obtain whole-genome resequencing data of the bovine embryo samples.
[0098] 2. Analysis of genome resequencing data
[0099] The whole-genome resequencing data of all obtained bovine embryo samples were analyzed. The specific steps are as follows:
[0100] (1) Sequencing data quality control
[0101] The raw sequencing reads obtained from sequencing were quality controlled using Fastp software. Specifically, read pairs with adapters were removed; read pairs in paired-end sequencing reads with N base content at any single end exceeding 10% of the read length were removed, as well as reads with low-quality bases (Q≤5) exceeding 50% of the read length were removed, thus obtaining Clean Reads.
[0102] (2) Comparison
[0103] The BWA software was used to align the quality-controlled Clean Reads to the bovine reference genome (ARS-UCD 1.3) to generate SAM files. Then, the Samtools software's view command was used to convert the SAM files to BAM format, and the sort command was used to sort the BAM files.
[0104] (3) Comparison quality assessment
[0105] The flagstat module of Samtools (1.9) software was used to calculate the alignment rate of paired-end reads to the reference genome in order to evaluate the quality and alignment rate of sequencing data.
[0106] (4) Copy number variation detection
[0107] CNVcaller software was used to perform CNV detection on each sample, detecting only Deletion and Duplication types.
[0108] 3. Selection analysis of CNVR among groups
[0109] Across the entire genome, 234,579 CNVRs were detected in the normally developing embryo population and 99,891 CNVRs were detected in the developmentally arrested embryo population, of which 517 CNVRs were shared by both populations. The population differentiation index (V) was used to further analyze the results. st To screen for differences in CNVR between the two groups. st Copy number variation (CNV) is a statistical indicator used to quantify the degree of differentiation in copy number variation among populations. By comparing the variance of copy number variation within and between populations, it identifies CNV regions that have significantly differentiated under natural selection or genetic drift. st The value ranges from 0 to 1. A larger value indicates a greater difference in copy number variation within that region among populations, and vice versa. The calculation formula is:
[0110] In the formula, V1 refers to the variance of the copy number of population 1; N1 refers to the number of individuals in population 1; V2 refers to the variance of the copy number of population 2; N2 refers to the number of individuals in population 2; V totalIt is the variance of the copy number of all individuals; N total This refers to the total number of individuals.
[0111] The experimental population was divided into two groups: a developmentally normal group and a developmentally arrested group. The absolute copy number of each CNVR was obtained using CNVcaller software, and the Vc of each CNVR between the two populations was calculated. st Value. Where V st There were 29 CNVRs with values greater than 0.25, indicating that these CNVRs were significantly differentiated between the two groups.
[0112] Select V st CNVR values greater than 0.3 were used as the differential CNVR values between the normal developmental group and the developmental arrest group for validation. The copy number changes between the normal developmental group and the developmental arrest group are shown in Table 1.
[0113] Table 1. CNVR information showing differences between the normal development group and the developmental arrest group
[0114] Note: In CNVR position, the part before the colon is the chromosome in which it is located, and the part after the colon is the physical location of the CNVR on the chromosome (the location is based on the bovine reference genome ARS-UCD version 1.3); in type, DUP indicates duplication.
[0115] Therefore, the extensive duplication of CNV fragments in regions such as CNVR-Vst4, CNVR-Vst5, CNVR-Vst7, and CNVR-Vst11 may be detrimental to healthy embryonic development and are potential sites that could lead to embryonic developmental arrest.
[0116] Example 2: CNVR quantitative PCR detection of differences in embryos at different developmental stages
[0117] 1. Six bovine embryo samples each of normal development and developmental arrest were collected for the experiment. To minimize damage to the bovine embryos or to avoid affecting their subsequent development, the bovine embryo samples in this embodiment consisted of 7 or 10 trophoblast cells from the embryo. The bovine embryo samples used in this embodiment were all Chinese Holstein dairy cow embryos produced by in vitro fertilization, which developed to the blastocyst or expanded blastocyst stage on days 6-7 after in vitro culture. Embryos that could form a normal blastocyst structure and have a complete inner cell mass and trophoblast cells were considered to be developing normally; while embryos that could not form a blastocyst or could not expand further, or that lacked an inner cell mass or had abnormal trophoblast cells were considered to be developing in arrest. These were provided by Shandong Aux Animal Husbandry Seed Industry Co., Ltd.
[0118] Six normally developing bovine embryo samples were designated as the normally developing embryo group.
[0119] Six bovine embryo samples with developmental arrest were designated as the embryonic developmental arrest group.
[0120] 2. Adopt The Single Cell Kit (Qiagen) is used to extract and amplify genomic DNA from the bovine embryo samples collected in step 1, and to dilute the genomic DNA of all bovine embryo samples to the same concentration.
[0121] 3. According to TB Ex Taq TM The instructions for the II (Tli RNaseH Plus) (RR820, Takara) kit state that the relative content of CNVR-Vst4, CNVR-Vst5, CNVR-Vst11, and CNVR-Vst7 in the genomic DNA of bovine embryo samples is detected by real-time quantitative PCR (using bovine BTF3 gene as an internal reference), which is the normalized relative copy number (NR).
[0122] The nucleotide sequences of the detection primers for each CNVR and internal reference gene are shown in Table 2. The primer specificity detection results are shown in Figure 1, indicating that the primers have good specificity.
[0123] Table 2. Primer information for detecting each CNVR and internal reference gene.
[0124] Figure 2 shows some of the results of real-time quantitative PCR detection. The results showed that, compared with the normal embryonic development group, the relative content (i.e., relative copy number) of CNVR-Vst5, CNVR-Vst7, and CNVR-Vst11 in the embryonic genome of the developmental arrest group was significantly increased (P<0.05), which proved that there were a large number of CNV fragment duplications in these regions, which is not conducive to the healthy development of the embryo and is a potential structural variation site that leads to embryonic developmental arrest.
[0125] Example 3, Verification Experiment
[0126] Forty-three bovine embryos obtained in Example 1 developed into blastocysts or expanded blastocysts on days 6-7 of the birthing process. Embryos that formed normal blastocyst structures with complete inner cell mass and trophoblast cells were defined as the normally developing group; while embryos that failed to form blastocysts or expand further, lacked an inner cell mass, or had abnormal trophoblast cells were defined as the developmentally arrested group, i.e., the abnormally developing group. To group embryos at the blastocyst or expanded blastocyst stage, the copy numbers or relative content values of four differential CNVRs (CNVR-Vst4, CNVR-Vst5, CNVR-Vst7, and CNVR-Vst11) were detected (using CNVcaller software or the method in Example 2) as input features to establish a developmental status discrimination model. Using "developmentally arrested embryos" as true positives and "normally developing embryos" as true negatives, a binomial logistic regression model was used to establish the grouping model, i.e., a binary classification label model was constructed, where the category was defined as: "0" representing a normally developing embryo and "1" representing a developmentally arrested embryo. The parameters in the model were estimated based on the maximum likelihood method. For any tested embryo, its copy number or relative content value is detected, and its probability of developmental arrest, p, is calculated by the following formula:
[0127] Where β0 is a constant term, and β1 to β n These are the coefficients of each variable, X1 to X... n p represents the copy number or relative content value of each CNVR, and p / (1-p) is a statistical indicator describing the intensity of an event, called the odds.
[0128] Finally, logit(p) = -26.488548 + 6.014 × X1 - 0.222 × X2 - 0.696 × X3 + 3.090 × X4; where X1 is the copy number or relative content value of CNVR-Vst4, X2 is the copy number or relative content value of CNVR-Vst5, X3 is the copy number or relative content value of CNVR-Vst11, and X4 is the copy number or relative content value of CNVR-Vst7.
[0129] The training and test sets were divided in a 2:1 ratio. The training set included 14 embryos with developmental arrest (SW012195, SW012285, SW013282, SW031194, SW102058, SW105054, SW102262, SW102059, SW-23-6-4, SW-21-6-1, SW012196, SW013283, SW031193, SW101057) and 16 normally developing embryos. (CW012125, CW012188, CW012189, CW012275, CW013281, CW016277, CW016278, CW013272, CW10 1049, CW102251, CW102255, CW105045, CW105046, CW-23-6-11-5, CW105052, CW-23-6-11-6). The test set included 6 embryos with developmental arrest (SW-21-6-2, SW-23-6-3, SW105198, SW016287, SW012284, SW101056) and 7 embryos with normal development (CW-21-6-18-1, CW-21-6-18-2, CW031192, CW102252, CW031191, CW012274, CW1010410).
[0130] Based on the above clustering model, embryonic development risk scores (p) were calculated for the validation set samples, and ROC curve analysis was performed (see Figure 3). The results showed that the AUC value was 0.833 (95% CI: 0.579–1.000), the sensitivity was 66.7%, and the specificity was 100%, indicating that the model's discriminative performance was optimal when the decision threshold was 0.9156. At this threshold, samples with p greater than or equal to 0.9156 were classified as developmentally arrested embryos, and samples with p less than 0.9156 were classified as normally developing embryos.
[0131] The results show that the above model can achieve quantitative clustering and accurate discrimination of blastocyst development status based on the relative copy number or relative content parameters of four CNVRs (CNVR-Vst4, CNVR-Vst5, CNVR-Vst7 and CNVR-Vst11).
[0132] Example 4: Copy number variation detection and identification of embryo-specific CNVR at different developmental stages
[0133] I. Obtaining and grouping bovine embryo samples
[0134] Same as step one in Example 1.
[0135] II. Obtaining and Amplifying Genomic DNA from Bovine Embryo Samples
[0136] use The Single Cell Kit (Qiagen) was used for the extraction and amplification of genomic DNA from bovine embryo samples. The total amount of genomic DNA in the bovine embryo samples was precisely quantified using a quorum analyzer, and the concentration was detected. The concentration and total amount of genomic DNA in all bovine embryo samples met the requirements for library preparation and could support whole-genome sequencing analysis.
[0137] Genomic DNA from all amplified bovine embryo samples was detected by agarose gel electrophoresis. Clear master bands of genomic DNA were visible in all bovine embryo samples, with no obvious degradation or non-specific amplification bands, indicating that the integrity and purity of the amplification products met the standards.
[0138] III. Detection of Copy Number Variations and Acquisition of CNVs Specific to Embryos at Different Developmental Stages
[0139] 1. Library construction and sequencing
[0140] All amplified bovine embryonic DNA samples were subjected to library construction (library type: WGS) and high-depth sequencing at 60G / sample to obtain whole-genome resequencing data of bovine embryonic samples.
[0141] 2. Analysis of genome resequencing data
[0142] The whole-genome resequencing data of all obtained bovine embryo samples were analyzed. The specific steps are as follows:
[0143] (1) Sequencing data quality control
[0144] Same as step 3.2 in Example 1 (1).
[0145] (2) Comparison
[0146] Same as step 3, 2 in Example 1 (2).
[0147] (3) Comparison quality assessment
[0148] Same as step 3, step 2 (3) in Example 1.
[0149] (4) Copy number variation detection
[0150] CNV detection and typing were performed on each sample using CNVcaller, CNVnator, and LUMPY software. Only the Deletion and Duplication types were detected. After constructing a high-confidence CNVR set, specific CNVRs present in the normal embryonic development group or the embryonic development arrest group were screened, and their functional genes were annotated and bioinformatics analyzed.
[0151] 3. Merge CNV results and screen for specific CNVRs
[0152] To improve the accuracy and reproducibility of CNV detection and reduce the false positive rate, SURVIVOR (v1.0.3) (https: / / github.com / fritzsedlazeck / SURVIVOR) was used to merge and optimize VCF files generated by three software programs: CNVs shorter than 50 bp were removed to eliminate possible short-fragment false positive variants; only CNVs supported by at least two software programs and with identical type (e.g., "DEL" for deletion, "DUP" for duplication) and orientation (e.g., chromosomal position order) were retained. If adjacent CNVs overlapped by at least one base, the R package was used to merge CNVs into CNV regions (CNVRs). Finally, CNVRs specifically present in each group were further screened based on the number of samples they were found to be present.
[0153] In the group with normal embryonic development, a total of 13 specific CNVRs were detected, of which 8 were located on chromosomes (Table 3). In the group with arrested embryonic development, a total of 92 specific CNVRs were screened, but only 4 of them were located on chromosomes (Table 4).
[0154] The eight specific CNVRs from the normal embryonic development group and the four specific CNVRs from the embryonic development arrest group were used as CNVR information that could represent the specificity of each group for subsequent verification and analysis.
[0155] Table 3. CNVR-specific information for the normal embryonic development group. Note: In CNVR positions, the part before the colon is the chromosome in which it is located, and the part after the colon is the physical location of the CNVR on the chromosome; in TPYE, DUP indicates a duplication and DEL indicates a deletion.
[0156] Table 4. CNVR information specific to the embryonic developmental arrest group. Note: In CNVR positions, the part before the colon is the chromosome in which it is located, and the part after the colon is the physical location of the CNVR on the chromosome; in TPYE, DUP indicates a duplication and DEL indicates a deletion.
[0157] Therefore, it can be seen that the large repetition of CNV segments in CNVR1, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7 and CNVR8, or the large deletion of CNV segments in CNVR2, may be beneficial to healthy embryonic development and are potential sites for maintaining normal embryonic development; while the large deletion of CNV segments in CNVR9, CNVR11 and CNVR12, or the large repetition of CNV segments in CNVR10, may be detrimental to healthy embryonic development and are potential sites for causing embryonic developmental arrest.
[0158] Example 5: Specific CNVR quantitative PCR detection of embryos at different developmental stages
[0159] 1. Six bovine embryo samples each of normal development and developmental arrest were collected for the experiment. To minimize damage to the bovine embryos or to avoid affecting their subsequent development, the bovine embryo samples in this embodiment can be 7 or 10 trophoblast cells from the excised embryos. The bovine embryo samples used in this embodiment were all Chinese Holstein dairy cow embryos produced by in vitro fertilization, which developed to the blastocyst or expanded blastocyst stage on days 6-7 after in vitro culture. Embryos that could form a normal blastocyst structure and have a complete inner cell mass and trophoblast cells were considered to be developing normally; while embryos that could not form a blastocyst or could not expand further, or that lacked an inner cell mass or had abnormal trophoblast cells were considered to be developing in arrest. These were provided by Shandong Aux Animal Husbandry Seed Industry Co., Ltd.
[0160] Six normally developing bovine embryo samples were designated as the normally developing embryo group.
[0161] Six bovine embryo samples with developmental arrest were designated as the embryonic developmental arrest group.
[0162] 2. Adopt The Single Cell Kit (Qiagen) is used to extract and amplify genomic DNA from the bovine embryo samples collected in step 1, and to dilute the genomic DNA of all bovine embryo samples to the same concentration.
[0163] 3. According to TB Premix Ex Taq TM The instructions for the II (Tli RNaseH Plus) (RR820, Takara) kit state that the relative content (i.e., relative copy number) of CNVR1, CNVR2, CNVR3, CNVR4, CNVR6, CNVR7, CNVR9, CNVR10, CNVR11, and CNVR12 in bovine embryonic genomic DNA samples is determined by real-time quantitative PCR.
[0164] The sequences of each CNVR detection primer are shown in Table 5. The nucleotide sequences of the BTF3 gene detection primers are shown in Table 2.
[0165] Table 5. Primer information for each CNVR detection
[0166] Partial results of real-time quantitative PCR detection are shown in Figure 4 (CNVR-CW1 is CNVR1, CNVR-CW7 is CNVR3, CNVR-CW19 is CNVR6, CNVR-CW20 is CNVR7, P<0.05) and Figure 5 (CNVR-SW15 is CNVR9, CNVR-SW27 is CNVR11, CNVR-SW29 is CNVR12, P<0.05). The results showed that compared with the embryonic development arrest group, the relative content (i.e., relative copy number) of the four repetitive CNVRs, namely CNVR1, CNVR3, CNVR6 and CNVR7, in the genome of the normal embryonic development group was significantly increased (P<0.05), which is consistent with the sequencing data analysis in Example 4. Compared with the normal embryonic development group, the relative content (i.e. relative copy number) of the three deletion CNVRs, namely CNVR9, CNVR11 and CNVR12, was significantly reduced in the embryonic genome of the developmental arrest group (P<0.05), which is consistent with the sequencing data analysis in Example 4.
[0167] The results showed that CNVRs CNVR1, CNVR2, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, and CNVR8 exhibited good reproducibility and could serve as potential biomarkers for normal embryonic development. Specifically, significant duplication of CNV fragments in CNVR1, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, and CNVR8, or significant deletion of CNV fragments in CNVR2, is beneficial for healthy embryonic development and represents potential sites for maintaining normal embryonic development. The results also indicated that CNVRs CNVR9, CNVR10, CNVR11, and CNVR12 exhibited good reproducibility and could serve as potential biomarkers for embryonic developmental arrest. Specifically, significant deletion of CNV fragments in CNVR9, CNVR11, and CNVR12, or significant duplication of CNV fragments in CNVR10, is detrimental to healthy embryonic development and represents potential sites leading to embryonic developmental arrest.
[0168] Example 6: Verification Experiment
[0169] The 43 bovine embryos obtained in Example 4 developed into blastocysts or expanded blastocysts on days 6-7 of the birthing process. Embryos that could form a normal blastocyst structure with a complete inner cell mass and trophoblast cells were defined as the normally developing embryonic group; while embryos that could not form a blastocyst or expand further, lacked an inner cell mass, or had abnormal trophoblast cells were defined as the developmentally arrested group, i.e., the abnormal embryonic group. To group the embryos at the blastocyst or expanded blastocyst stage, the copy numbers or relative abundance values of eight specific CNVRs (CNVR1, CNVR3, CNVR6, CNVR7, CNVR9, CNVR10, CNVR11, and CNVR12) were detected (using CNVnator software or the method in Example 5) as input features to establish a developmental status discrimination model. Using "developmentally arrested embryos" as true positives and "normally developing embryos" as true negatives, a binomial logistic regression model was established. This model employs binary classification labels, where "0" represents a normally developing embryo and "1" represents a developmentally arrested embryo. All parameters in the model were estimated using the maximum likelihood method. For any tested embryo, its copy number or relative content value was obtained, and its probability of developmental arrest, p, was calculated using the following formula:
[0170] Where β0 is a constant term, and β1 to β n These are the coefficients of each variable, X1 to X... n p represents the copy number or relative content value of each CNVR, and p / (1-p) is a statistical indicator describing the intensity of an event, called the odds.
[0171] Finally, logit(p) = 0.696 + 0.014 × X1 - 1.424 × X2 - 1.813 × X3 - 0.038 × X4 + 27.613 × X5 + 9.911e-15 × X6 + 38.999 × X7 + 63.306 × X8; where X1 is the copy number or relative content value of CNVR1, X2 is the copy number or relative content value of CNVR3, X3 is the copy number or relative content value of CNVR6, X4 is the copy number or relative content value of CNVR7, X5 is the copy number or relative content value of CNVR9, X6 is the copy number or relative content value of CNVR10, X7 is the copy number or relative content value of CNVR11, and X8 is the copy number or relative content value of CNVR12.
[0172] The training and test sets were divided in a 2:1 ratio. The training set included 14 embryos with developmental arrest (SW012285, SW031194, SW101056, SW102058, SW105054, SW102059, SW105198, SW-23-6-3, SW-21-6-2, SW-23-6-4, SW-21-6-1, SW013283, SW031193, SW101057) and 16 normally developing embryos (CW). 012125, CW012188, CW012189, CW013281, CW016278, CW013272, CW-21-6-18-1, CW-21-6-18-2, C W031191, CW031192, CW102251, CW102255, CW105045, CW105046, CW-23-6-11-5, CW-23-6-11-6). The test set included 6 embryos with developmental arrest (SW012196, SW013282, SW012284, SW102262, SW016287, SW012195) and 7 embryos with normal development (CW102252, CW101049, CW016277, CW012274, CW012275, CW1010410, CW105052).
[0173] Based on the above clustering model, an embryonic development risk score p was calculated for the validation set samples, and ROC curve analysis was performed (see Figure 6). The results showed that the AUC value was 0.952 (95% CI: 0.841–1.000), the sensitivity was 83.3%, and the specificity was 100%, meaning that the model's discriminative performance was optimal when the decision threshold was 0.6608. At this threshold, samples with p greater than or equal to 0.6608 were classified as embryos with developmental arrest, while samples with p less than or equal to 0.6608 were classified as embryos with normal development.
[0174] The results show that the above model can achieve quantitative clustering and accurate discrimination of blastocyst development status based on the relative copy number or relative content parameters of eight CNVRs (CNVR1, CNVR3, CNVR6, CNVR7, CNVR9, CNVR10, CNVR11 and CNVR12).
[0175] The present invention has been described in detail above. Those skilled in the art will recognize that the invention can be practiced in a wide range of ways with equivalent parameters, concentrations, and conditions without departing from its spirit and scope, and without requiring unnecessary experiments. While specific embodiments have been provided, it should be understood that further modifications can be made to the invention. In summary, according to the principles of the invention, this application is intended to include any changes, uses, or improvements to the invention, including changes made using conventional techniques known in the art that depart from the scope disclosed herein. Industrial applicability
[0176] This invention clarifies the impact of large-segment genomic genetic variations (CNVs) on the development of bovine embryos induced by in vitro fertilization. It finds that large duplications of CNV segments in at least one region of CNVR1, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, and CNVR8, or large deletions of CNV segments in the CNVR2 region, are beneficial to healthy embryonic development and represent potential sites for maintaining normal embryonic development. Conversely, large deletions of CNV segments in at least one region of CNVR9, CNVR11, and CNVR12, or large duplications of CNV segments in the CNVR10 region, are detrimental to healthy embryonic development. The invention identifies potential sites of embryonic developmental arrest, specifically 12 CNVRs, which can predict whether bovine embryos will develop normally and whether they are suitable for embryo transfer. Furthermore, it was found that if the content and / or copy number of four CNVRs (CNVR-Vst5, CNVR-Vst11, CNVR-Vst7, and / or CNVR-Vst4) in the genome of bovine embryos cultured in vitro at the blastocyst or expanded blastocyst stage are not significantly different from those of normal bovine embryos at the blastocyst or expanded blastocyst stage, the bovine embryo can develop normally and is suitable for embryo transfer; otherwise, the bovine embryo is developmentally arrested, and embryo transfer is not recommended. Therefore, this invention can scientifically determine the developmental status of bovine embryos, thereby providing transfer strategies and decisions, and has significant application value.
Claims
1. A kit comprising a product for detecting the content and / or copy number of CNVR combination 1 in bovine embryo genome and / or a product for detecting the content and / or copy number of CNVR combination 2 in bovine embryo genome; The CNVR combination 1 includes CNVR1, CNVR2, CNVR3, CNVR4, CNVR5, CNVR6, CNVR7, CNVR8, CNVR9, CNVR10, CNVR11 and / or CNVR12; The nucleotide sequence of CNVR1 is shown as positions 87257601-87261000 on chromosome 1 of the bovine genome; the nucleotide sequence of CNVR2 is shown as positions 10962442-10967439 on chromosome 6 of the bovine genome; the nucleotide sequence of CNVR3 is shown as positions 73069301-73075200 on chromosome 7 of the bovine genome; the nucleotide sequence of CNVR4 is shown as positions 9559601-9564600 on chromosome 15 of the bovine genome; the nucleotide sequence of CNVR5 is shown as positions 42400401-42411000 on chromosome 17 of the bovine genome; the nucleotide sequence of CNVR6 is shown as positions 45089601-45097500 on chromosome 19 of the bovine genome; The nucleotide sequence of CNVR7 is shown as positions 2431101-2439900 on chromosome 20 of the bovine genome; the nucleotide sequence of CNVR8 is shown as positions 27338101-27364000 on chromosome 25 of the bovine genome; the nucleotide sequence of CNVR9 is shown as positions 41627101-41632400 on chromosome 15 of the bovine genome; the nucleotide sequence of CNVR10 is shown as positions 21750901-21754000 on chromosome 23 of the bovine genome; the nucleotide sequence of CNVR11 is shown as positions 5217901-5222300 on chromosome 27 of the bovine genome; and the nucleotide sequence of CNVR12 is shown as positions 19154801-19158600 on chromosome 29 of the bovine genome. The CNVR combination 2 includes CNVR-Vst5, CNVR-Vst11, CNVR-Vst7 and / or CNVR-Vst4; The nucleotide sequence of CNVR-Vst5 is shown as positions 60638401-60642400 on chromosome 5 of the bovine genome; the nucleotide sequence of CNVR-Vst11 is shown as positions 71203201-71205200 on chromosome 11 of the bovine genome; the nucleotide sequence of CNVR-Vst7 is shown as positions 18346401-18350000 on chromosome 7 of the bovine genome; and the nucleotide sequence of CNVR-Vst4 is shown as positions 44117201-44118800 on chromosome 4 of the bovine genome. The kit is intended for predicting bovine embryonic development and / or for preimplantation diagnosis of bovine embryos.
2. The reagent kit according to claim 1, characterized in that: The product used to detect the content and / or copy number of CNVR combination 1 in bovine embryo genome includes primer pair CW1 for detecting CNVR1, primer pair CW6 for detecting CNVR2, primer pair CW7 for detecting CNVR3, primer pair CW15 for detecting CNVR4, primer pair CW19 for detecting CNVR6, primer pair CW20 for detecting CNVR7, primer pair SW15 for detecting CNVR9, primer pair SW23 for detecting CNVR10, primer pair SW27 for detecting CNVR11, and / or primer pair SW29 for detecting CNVR12. The product used to detect the content and / or copy number of CNVR combination 2 in bovine embryo genome includes primer pair Vst5 for detecting CNVR-Vst5, primer pair Vst11 for detecting CNVR-Vst11, primer pair Vst7 for detecting CNVR-Vst7, and / or primer pair Vst4 for detecting CNVR-Vst4. Furthermore, Primer pair CW1 consists of primer CNVR-CW1F with nucleotide sequence as shown in SEQ ID No. 11 and primer CNVR-CW1R with nucleotide sequence as shown in SEQ ID No. 12; primer pair CW6 consists of primer CNVR-CW6F with nucleotide sequence as shown in SEQ ID No. 13 and primer CNVR-CW6R with nucleotide sequence as shown in SEQ ID No. 14; primer pair CW7 consists of primer CNVR-CW7F with nucleotide sequence as shown in SEQ ID No. 15 and primer CNVR-CW7R with nucleotide sequence as shown in SEQ ID No. 16; primer pair CW15 consists of primer CNVR-CW15F with nucleotide sequence as shown in SEQ ID No. 17 and primer CNVR-CW15R with nucleotide sequence as shown in SEQ ID No. 18; primer pair CW19 consists of primer CNVR-CW19F with nucleotide sequence as shown in SEQ ID No. 19 and primer CNVR-CW19R with nucleotide sequence as shown in SEQ ID No.
14. Primer pair SW15 consists of primer CNVR-CW19R as shown in SEQ ID No. 20; primer pair CW20 consists of primer CNVR-CW20F with nucleotide sequence as shown in SEQ ID No. 21 and primer CNVR-CW20R with nucleotide sequence as shown in SEQ ID No. 22; primer pair SW15 consists of primer CNVR-SW15F with nucleotide sequence as shown in SEQ ID No. 23 and primer CNVR-SW15R with nucleotide sequence as shown in SEQ ID No. 24; primer pair SW23 consists of primer CNVR-SW23F with nucleotide sequence as shown in SEQ ID No. 25 and primer CNVR-SW23R with nucleotide sequence as shown in SEQ ID No. 26; primer pair SW27 consists of primer CNVR-SW27F with nucleotide sequence as shown in SEQ ID No. 27 and primer CNVR-SW27R with nucleotide sequence as shown in SEQ ID No. 28; primer pair SW29 consists of primer CNVR-SW29F with nucleotide sequence as shown in SEQ ID No. 29 and primer CNVR-SW29F with nucleotide sequence as shown in SEQ ID No.
28. Primer No. 30 consists of primer CNVR-SW29R; primer pair Vst5 consists of primer CNVR-Vst 5F with nucleotide sequence as shown in SEQ ID No. 3 and primer CNVR-Vst 5R with nucleotide sequence as shown in SEQ ID No. 4; primer pair Vst11 consists of primer CNVR-Vst 11F with nucleotide sequence as shown in SEQ ID No. 5 and primer CNVR-Vst 11R with nucleotide sequence as shown in SEQ ID No. 6; primer pair Vst7 consists of primer CNVR-Vst 7F with nucleotide sequence as shown in SEQ ID No. 7 and primer CNVR-Vst 7F with nucleotide sequence as shown in SEQ ID No. 30.Primer CNVR-Vst 7R, as shown in SEQ ID No. 8, is used; primer pair Vst4 consists of primer CNVR-Vst 4F with nucleotide sequence as shown in SEQ ID No. 1 and primer CNVR-Vst 4R with nucleotide sequence as shown in SEQ ID No.
2.
3. The reagent kit according to claim 1, characterized in that: The CNVR combination 1 consists of CNVR1, CNVR3, CNVR6, CNVR7, CNVR9, CNVR10, CNVR11 and CNVR12; The CNVR combination 2 consists of CNVR-Vst4, CNVR-Vst5, CNVR-Vst7 and CNVR-Vst11.
4. The kit according to claim 1, characterized in that: The content is a relative content; the copy number is a relative copy number.
5. The reagent kit according to claim 1, characterized in that: The bovine embryos mentioned are bovine embryos cultured through in vitro fertilization.
6. The reagent kit according to claim 1, characterized in that: The bovine embryos referred to are bovine embryos that have developed to the blastocyst or expanded blastocyst stage.
7. The kit according to any one of claims 1 to 6, characterized in that: The kit also includes carrier A, carrier B and / or carrier C: The carrier A contains the following information: A bovine embryo that has developed to the blastocyst or expanded blastocyst stage is used as the test sample; a halted bovine embryo that has developed to the blastocyst or expanded blastocyst stage is used as reference sample 1; and a normal bovine embryo that has developed to the blastocyst or expanded blastocyst stage is used as reference sample 2. The content and / or copy number of CNVR combination 1 in the test sample, reference sample 1, and reference sample 2 are detected. Then, based on the differences in the content and / or copy number of CNVR combination 1 in the test sample, reference sample 1, and reference sample 2, the embryonic development status of the test sample is predicted or preimplantation genetic diagnosis is performed. The carrier B contains the following information: comparing the copy number or relative content value of each CNVR in CNVR combination 1 or CNVR combination 2 of a bovine embryo that has developed to the blastocyst or expanded blastocyst stage with a determination threshold to determine the developmental status of the tested bovine embryo; and diagnosing whether to perform bovine embryo implantation based on the results of the bovine embryo developmental status prediction method. The carrier C contains the following: using bovine embryos developed to the blastocyst or expanded blastocyst stage as the test sample, and using normal bovine embryos developed to the blastocyst or expanded blastocyst stage as the reference sample 3, the content and / or copy number of the CNVR combination 2 in the test sample and the reference sample 3 are detected; then, based on the difference in the content and / or copy number of the CNVR combination 2 in the test sample and the reference sample 3, the embryonic development status of the test sample is predicted or preimplantation genetic diagnosis is performed.
8. The product according to any one of claims 1 to 6 for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome and / or the product according to any one of claims 1 to 6 for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome, in predicting the developmental status of bovine embryos and / or in preimplantation genetic diagnosis of bovine embryos; preferably, the bovine embryo is a bovine embryo that has developed to the blastocyst or expanded blastocyst stage.
9. The product of any one of claims 1 to 6 for detecting the content and / or copy number of CNVR combination 1 in the bovine embryo genome and the application of vector A or vector B of claim 7 in predicting the developmental status of bovine embryos and / or in preimplantation diagnosis of bovine embryos; preferably, the bovine embryo is a bovine embryo that has developed to the blastocyst or expanded blastocyst stage.
10. The product of any one of claims 1 to 6 for detecting the content and / or copy number of CNVR combination 2 in the bovine embryo genome and the application of vector C or vector B of claim 7 in predicting the developmental status of bovine embryos and / or in preimplantation diagnosis of bovine embryos; preferably, the bovine embryo is a bovine embryo that has developed to the blastocyst or expanded blastocyst stage.
11. A method for predicting the developmental status of bovine embryos and / or for preimplantation genetic diagnosis of bovine embryos, comprising the following steps: S1. Obtain the copy number or relative content value of each CNVR in the CNVR combination of the tested bovine embryo sample; S2. Input the copy value or relative content value into the trained artificial intelligence model to obtain the output value, and compare the output value with the judgment threshold to obtain the bovine embryo development status, wherein the bovine embryo development status is normal development or development arrest. The artificial intelligence model is an artificial intelligence model trained with the copy number or relative content of each CNVR in the CNVR combination of normally developing embryos and developmentally arrested embryos as input data and the developmental arrest probability of bovine embryos as output. The CNVR combination is CNVR combination 1 as described in claim 1 or 3, or CNVR combination 2 as described in claim 1 or 3. Furthermore, the suitability for bovine embryo implantation can be determined based on the bovine embryo's developmental stage: if the bovine embryo is developing normally, embryo transfer can be performed; if the bovine embryo is in a state of developmental arrest, embryo implantation is not recommended.
12. A data processing device for predicting the developmental status of bovine embryos, comprising a memory, a processor, and a computer program stored in the memory, wherein, The processor executes the computer program to perform the following steps: P1. Data reception: Receive the copy number or relative content value of each CNVR in the CNVR combination of the bovine embryo sample to be tested, and obtain the sample data; P2. Data processing: The sample data is input into a trained artificial intelligence model to obtain an output value, and the output value is compared with a judgment threshold to obtain the bovine embryonic development status, which is either normal development or developmental arrest. The artificial intelligence model is an artificial intelligence model trained with the copy number or relative content of each CNVR in the CNVR combination of normally developing embryos and developmentally arrested embryos as input data and the developmental arrest probability of bovine embryos as output. The CNVR combination is CNVR combination 1 as described in claim 1 or 3, or CNVR combination 2 as described in claim 1 or 3.
13. A computer-readable storage medium having a computer program stored thereon, which, when executed by a processor, implements the steps of the method of claim 11.
14. A computer program product comprising a computer program that, when executed by a processor, implements the steps of the method of claim 11.
